Search Results - "Pimm, M V"

Refine Results
  1. 1

    Prevention of renal tubule re-absorption of radiometal (indium-111) labelled Fab fragment of a monoclonal antibody in mice by systemic administration of lysine by Pimm, M V, Gribben, S J

    Published in European Journal of Nuclear Medicine (01-07-1994)
    “…Systemic administration of lysine to mice injected with indium-111-labelled Fab fragment of a monoclonal antibody has been shown to reduce renal…”
    Get full text
    Journal Article
  2. 2

    Influence of carrier on biodistribution and in vitro cytotoxicity of methotrexate-branched polypeptide conjugates by Hudecz, F, Clegg, J. A, Kajtar, J, Embleton, M. J, Pimm, M. V, Szekerke, M, Baldwin, R. W

    Published in Bioconjugate chemistry (01-01-1993)
    “…Methotrexate (MTX) has been conjugated to various structurally related, synthetic, branched polypeptides containing a poly(L-Lys) backbone by the aid of…”
    Get full text
    Journal Article
  3. 3

    Circulating antigen: Bad or good for immunoscintigraphy? by Pimm, Malcolm V.

    Published in Nuclear medicine and biology (01-02-1995)
    “…There is ample evidence to show that circulating antigen can restrict effective localization of radiolabelled murine monoclonal antibodies in human tumours…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Influence of syngeneic (anti-idiotypic) antibody responses on biodistribution and tumour localisation of murine monoclonal antibodies and fragments by Pimm, M V, Gribben, S J

    Published in Anticancer research (01-01-1993)
    “…Balb/c mice were immunised with three different syngeneic monoclonal antibodies (Mabs). Following injection of radiolabelled Mabs into mice with anti-antibody…”
    Get more information
    Journal Article
  6. 6

    Carrier design: biodistribution of branched polypeptides with a poly(L-lysine) backbone by Clegg, J. A, Hudecz, F, Mezo, G, Pimm, M. V, Szekerke, M, Baldwin, R. W

    Published in Bioconjugate chemistry (01-11-1990)
    “…The biodistribution has been examined in mice of a range of synthetic branched polypeptides which are based on a polylysine backbone but which differ in ionic…”
    Get full text
    Journal Article
  7. 7

    Drug-monoclonal antibody conjugates for cancer therapy: potentials and limitations by Pimm, M V

    “…The development of monoclonal antibodies against antigens associated preferentially with human tumors has reawakened interest in the use of antibodies as…”
    Get more information
    Journal Article
  8. 8

    A bispecific monoclonal antibody against methotrexate and a human tumour associated antigen augments cytotoxicity of methotrexate-carrier conjugate by PIMM, M. V, ROBINS, R. A, EMBLETON, M. J, JACOBS, E, MARKHAM, A. J, CHARLESTON, A, BALDWIN, R. W

    Published in British journal of cancer (01-04-1990)
    “…A bispecific monoclonal antibody, reactive with methotrexate (MTX) and a tumour associated antigen (gp72) has been produced by fusing spleen cells from MTX…”
    Get full text
    Journal Article
  9. 9

    Immunoscintigraphy of ovarian carcinoma using a monoclonal antibody (111In-NCRC48) defining a polymorphic epithelial mucin (PEM) epitope by Perkins, A C, Symonds, I M, Pimm, M V, Price, M R, Wastie, M L, Symonds, E M

    Published in Nuclear medicine communications (01-07-1993)
    “…An anti-polymorphic epithelial mucin (PEM) monoclonal antibody NCRC48 (IgG3) has been tested for its capacity to localize in tumours according to accepted…”
    Get more information
    Journal Article
  10. 10

    Recombinant ricin toxin A chain cytotoxicity against carcinoembryonic antigen expressing tumour cells mediated by a bispecific monoclonal antibody and its potentiation by ricin toxin B chain by EMBLETON, M. J, CHARLESTON, A, ROBINS, R. A, PIMM, M. V, BALDWIN, R. W

    Published in British journal of cancer (01-05-1991)
    “…A bispecific monoclonal antibody recognising both carcinoembryonic antigen (CEA) and ricin toxin A chain (RTA) was tested for its ability to target recombinant…”
    Get full text
    Journal Article
  11. 11

    Evaluation of monoclonal idiotypic-specific antibodies as clearing antibodies for enhancement of target localisation by tumour-specific monoclonal antibodies: diversity of effects in nude mice with human tumour xenografts by Pimm, M V, Gribben, S J

    Published in European Journal of Nuclear Medicine (01-06-1992)
    “…Three tumour-specific monoclonal antibodies (MoAbs) showed localisation in human tumour xenografts in nude mice, although the tumour discrimination was limited…”
    Get full text
    Journal Article
  12. 12

    The Characteristics of Blood-Borne Radiolabels and the Effect of Anti-Mouse IgG Antibodies on Localization of Radiolabeled Monoclonal Antibody in Cancer Patients by Pimm, Malcolm V, Perkins, Alan C, Armitage, Nicholas C, Baldwin, Robert W

    Published in The Journal of nuclear medicine (1978) (01-09-1985)
    “…Quantitative and qualitative aspects of the blood survival of 131I and 111In-labeled monoclonal antibody 791T/36 have been examined in patients with…”
    Get full text
    Journal Article
  13. 13

    The influence of syngeneic anti-idiotypic antibody on the biodistribution of an anti-tumour monoclonal antibody in BALB/c mice by Pimm, M V, Durrant, L G, Baldwin, R W

    Published in International journal of cancer (15-01-1989)
    “…BALB/c mice were immunized against syngeneic murine 791T/36 monoclonal antibody (MAb) by intraperitoneal (i.p.) injection of the antibody conjugated to ricin…”
    Get more information
    Journal Article
  14. 14

    Toxicity associated with the formation and clearance of immune complexes between antitumour monoclonal antibodies and syngeneic anti-idiotypic antibodies in mice by PIMM, M. V, GRIBBEN, S. J

    “…We have previously shown that Balb/c mice immunised against syngeneic monoclonal antibodies (mAbs), so that they have anti-idiotypic responses against those…”
    Get full text
    Journal Article
  15. 15

    Influence of syngeneic monoclonal anti-idiotypic antibodies to murine monoclonal antibodies against tumor-associated antigens on the biodistribution of their target antibodies and their fragments by PIMM, M. V, DEMIGNOT, S, GRIBBEN, S. J

    “…The effect of syngeneic anti-idiotypic (anti-id) antibodies on the biodistribution of three murine monoclonal antibodies (mAb) against human tumour-associated…”
    Get full text
    Journal Article
  16. 16

    Capture of recombinant ricin A chain by a bispecific anti-RTA : anti-CEA monoclonal antibody pre-targeted to a human gastric carcinoma xenograft in nude mice by PIMM, M. V, ROBINS, R. A, BALDWIN, R. W

    “…A bispecific antibody against carcinoembryonic antigen (CEA) and ricin A chain has been shown to localise in a CEA-producing human tumour xenograft. When…”
    Get full text
    Journal Article
  17. 17

    Targeting of bladder cancer with monoclonal antibody NCRC48--a possible approach for intravesical therapy by Kunkler, R B, Bishop, M C, Green, D J, Pimm, M V, Price, M R, Frier, M

    Published in British journal of urology (01-07-1995)
    “…To determine the localization of the anti-MUC1 mucin monoclonal antibody (mAb) NCRC48 to bladder cancer following intravesical administration. mAb NCRC48…”
    Get more information
    Journal Article
  18. 18
  19. 19

    Biodistribution of ricin toxin A chain-monoclonal antibody 791T/36 immunotoxin and influence of hepatic blocking agents by Byers, V S, Pimm, M V, Pawluczyk, I Z, Lee, H M, Scannon, P J, Baldwin, R W

    Published in Cancer research (Chicago, Ill.) (15-10-1987)
    “…Immunotoxin constructed by conjugating ricin A chain to monoclonal antibody 791T/36 has a markedly altered biodistribution when compared to unconjugated…”
    Get full text
    Journal Article
  20. 20

    The localization of an anti-tumour monoclonal antibody (791T/36) in gastrointestinal tumours by Armitage, N C, Perkins, A C, Pimm, M V, Farrands, P A, Baldwin, R W, Hardcastle, J D

    Published in British journal of surgery (01-06-1984)
    “…Fifty-six patients with gastrointestinal cancers and four patients with benign colorectal tumours have been injected with radiolabelled anti-tumour monoclonal…”
    Get more information
    Journal Article